- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05585736
Cycloplegia and Refractive Status
October 14, 2022 updated by: Ehab Tharwat, Al-Azhar University
Effect of Cycloplegia on the Refractive Status of Egyptian Children
Myopia is a public health problem, affecting the general population worldwide.
The common modalities for correcting myopia include spectacles, contact lenses, and surgical procedures.
Cycloplegic refraction is considered the gold standard for measuring refractive errors, especially in children.
It has been well-established that generally myopia could be overestimated and hyperopia be underestimated if refraction was performed without cycloplegia.
Study Overview
Study Type
Interventional
Enrollment (Actual)
388
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New Damietta
-
Damieta, New Damietta, Egypt, 34517
- Ehab tharwat
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
2 years to 10 years (CHILD)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Myopia or Hyperopia or compound myopic astigmatism.
- Normal intra ocular pressure (IOP≤21 mmHg.
- Age > 2 years and < 10 years
Exclusion Criteria:
- Unwilling to participate in the study.
- Previous ocular surgery
- Any diagnosed ocular disease
- History of ocular trauma
- Irregular astigmatism on corneal topography.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
OTHER: Cycloplegic refraction
All refractions were measured before and after cycloplegic addition to the eye.
|
they are drugs that paralyze the ciliary muscles and cause relaxation of accommodation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sphere of the eye
Time Frame: Baseline
|
It means that the correction for nearsightedness or farsightedness is spherical, equal in all meridians of the eye.
This indicates the amount of lens power, measured in diopters (D), prescribed to correct nearsightedness or farsightedness.
If the number appearing under this heading has a minus sign (-), you are nearsighted; if the number has a plus sign (+) or is not preceded by a plus sign or a minus sign, you are farsighted.
It is measured by Auto-refractor
|
Baseline
|
Sphere of the eye
Time Frame: Immediate after 30 minutes of cycloplegic addition
|
It means that the correction for nearsightedness or farsightedness is spherical, equal in all meridians of the eye.
This indicates the amount of lens power, measured in diopters (D), prescribed to correct nearsightedness or farsightedness.
If the number appearing under this heading has a minus sign (-), you are nearsighted; if the number has a plus sign (+) or is not preceded by a plus sign or a minus sign, you are farsighted.
It is measured by Auto-refractor
|
Immediate after 30 minutes of cycloplegic addition
|
cylinder of the eye
Time Frame: Baseline
|
This indicates the amount of lens power for astigmatism and represents the difference in the greatest and weakest powers of the eye, usually separated by 90 degrees.
If nothing appears in this column, either you have no astigmatism, or your astigmatism is so slight that it is not necessary to correct it with your eyeglass lenses.
The number in the cylinder column may be preceded with a minus sign (for the correction of nearsighted astigmatism) or a plus sign (for farsighted astigmatism).
Cylinder power always follows sphere power in an eyeglass prescription.
It is measured by Autorefractor.
|
Baseline
|
cylinder
Time Frame: Immediate after 30 minutes after cycloplegia
|
This indicates the amount of lens power for astigmatism and represents the difference in the greatest and weakest powers of the eye, usually separated by 90 degrees.
If nothing appears in this column, either you have no astigmatism, or your astigmatism is so slight that it is not necessary to correct it with your eyeglass lenses.
The number in the cylinder column may be preceded with a minus sign (for the correction of nearsighted astigmatism) or a plus sign (for farsighted astigmatism).
Cylinder power always follows sphere power in an eyeglass prescription.
It is measured by Autorefractor
|
Immediate after 30 minutes after cycloplegia
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
September 20, 2021
Primary Completion (ACTUAL)
September 1, 2022
Study Completion (ACTUAL)
September 15, 2022
Study Registration Dates
First Submitted
September 17, 2022
First Submitted That Met QC Criteria
October 14, 2022
First Posted (ACTUAL)
October 19, 2022
Study Record Updates
Last Update Posted (ACTUAL)
October 19, 2022
Last Update Submitted That Met QC Criteria
October 14, 2022
Last Verified
October 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Cycloplegia
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cycloplegia
-
Shanghai Eye Disease Prevention and Treatment CenterRecruitingRefractive Errors | Myopia | Accomodation | CycloplegiaChina
-
Islamic Hospital, JordanJordan University of Science and Technology; Yarmouk UniversityRecruitingRefractive Errors | Vision Disorders | Esotropia | CycloplegiaJordan, Qatar